Healthcare

Don't 'Wait and Watch': Doctors' Message to Indian Women on Breast Cancer

Every year, more than 2.3 lakh Indian women hear the words: "you have breast cancer." It is now the most common cancer among women in India, accounting for roughly 27% of all female cancer cases, ahead of cervical cancer, which long held that spot.

Don't 'Wait and Watch': Doctors' Message to Indian Women on Breast Cancer

Every year, more than 2.3 lakh Indian women hear the words: “you have breast cancer”. It is now the most common cancer among women in India, accounting for roughly 27% of all female cancer cases, ahead of cervical cancer, which long held that spot.

What sets the Indian picture apart is who gets it, and when. Indian women are typically diagnosed about a decade earlier than their counterparts in the West, with many cases in premenopausal women aged 30 to 55: women in the middle of their careers, raising children and caring for ageing parents. And by the time many reach a doctor, the disease has already advanced. Nearly 60% of cases are diagnosed at Stage III or IV.

Why are Indian women diagnosed younger?

Dr. Manish Sahni, Consultant Surgical Oncologist, Kailash Hospital, Noida, said, “Breast cancer in Indian women is influenced by a combination of genetic, hormonal, reproductive, and lifestyle-related factors. The relatively younger age at diagnosis may also reflect differences in population demographics and disease patterns. However, there is no single explanation for this trend. More research is needed to understand this; however, the importance of bringing awareness about breast self-examination in the early 20s and annual screening and mammography starting at the age of 40 years needs more emphasis.”

Dr. Camelia Maitra, Consultant, Obstetrics and Gynaecology, Fortis Hospital, Shalimar Bagh, said, “Late pregnancy, fewer children and late menopause raise risk slightly. Breastfeeding helps, and so do staying active and watching your weight. Pills and HRT carry a small risk that depends on age and duration, so we decide case by case. The bigger danger is skipping check-ups, not the choices you made.”

Dr. Sahni added, “Some breast cancers diagnosed in younger women may have more aggressive biological features, especially triple-negative breast cancers, but this is not the case for every patient. Tumour subtype, stage and individual health factors are important in determining prognosis.”

Why diagnosis comes late and the signs women ignore

Dr. Sahni said, “Delayed diagnosis can result from limited awareness of symptoms, lack of education about breast health, hesitation to seek medical advice and barriers to timely evaluation. At advanced stages, treatment may require a combination of therapies and can become more complex. Such cases may also increase the financial burden. Early diagnosis generally offers more treatment options and is associated with better outcomes, making timely medical consultation particularly important.”

Dr. Vandana Mittal, Principal Consultant, Obstetrics and Gynaecology, Paras Health, Panchkula, said, “One common myth is that women without a family history cannot develop breast cancer. In reality, many patients have no known family history. Another misconception is that cancerous lumps are always painful, whereas they may be painless. Mammograms do not cause breast cancer; they use low-dose X-rays to detect abnormalities, often before they can be felt.”

Dr. Maitra said, “Most women notice something and tell themselves it will settle. Any new lump, thickening, skin dimpling, a nipple turning inward, bloody discharge or a lump under the arm needs checking. The painless lump is the one women dismiss most and the one I worry about. If a change lasts beyond one period cycle, please don’t wait and watch. Consult a doctor.”

When to start screening

Dr. Mittal said, “India needs a stronger focus on risk awareness, early detection and timely diagnosis within its public healthcare system. Screening guidelines should be supported by accessible clinical breast examinations, risk assessment and clear referral pathways, particularly for women with symptoms or higher risk. Strengthening diagnostic infrastructure, training healthcare workers and ensuring affordable follow-up care is equally important.”

Dr. Maitra said, “Guidelines vary, but many suggest starting around 40, and earlier if your mother or sister had breast or ovarian cancer, usually about ten years before their age at diagnosis. Every woman over 40 should have this conversation with her doctor, even if she feels perfectly well.”

Bridging the urban–rural gap

Dr. Mittal commented on the urban–rural gap in screening and diagnosis, highlighting what would make community-level screening effective: “The gap is significant, particularly in access to trained specialists, diagnostic facilities and timely follow-up.” Community-level screening can help bridge this divide through trained ASHA workers, awareness sessions and clinical breast examinations at primary healthcare centres. Mobile diagnostic units and clear referral pathways are equally important to ensure women with suspicious findings receive timely evaluation and treatment.”

Dr. Sahni said, “While urban areas may report a higher incidence, rural communities also need attention, particularly regarding awareness, timely diagnosis and access to specialised care. Both settings require sustained efforts towards early detection.”

For women in smaller towns and villages, Dr. Maitra advised, “Don’t wait to find a specialist. Go to the nearest doctor you can reach, whether that is the primary health centre, a government hospital or a trusted local gynaecologist, and ask for a breast examination. If there is a lump, ask to be referred to the district hospital for an ultrasound or biopsy. Take someone with you, and don’t let distance become the reason you delay.”

Advances in treatment

Dr. Sahni said, “Advances in breast cancer care have enabled more personalised treatment. Targeted therapy and immunotherapy benefit eligible patients, while breast-conserving surgery with various oncoplastic breast surgery options offer an effective option for many women when clinically appropriate. Access to these treatments is expanding beyond major metros, although availability may vary by centre. Timely diagnosis, accurate testing and consultation with multidisciplinary teams remain essential to selecting the most appropriate treatment.”